Article Text

Download PDFPDF
Evidence of safety of metformin in people with kidney disease

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

A community-based cohort study has attempted to clarify safety concerns surrounding metformin use in people with type 2 diabetes and chronic kidney disease (CKD).1 In 2016, the USA Food and Drug Administration (FDA) changed the recommendations for metformin for diabetes to expand its use in certain patients with reduced kidney function.2 However, despite this and other changes to metformin labelling, it was thought that many people may be missing out on the possible benefits of treatment with metformin because of persisting concerns over drug …

View Full Text